Procainamide-Induced Myasthenia-like Weakness in a Patient With Peripheral Neuropathy
Authors:
- Enayatolah NiakanENEnayatolah Niakan
- Tulio E. BertoriniTBTulio E. Bertorini
- Sergio R. AcchiardoSASergio R. Acchiardo
- Mary F. WernerMWMary F. Werner
- 1 June 1981
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 38 (6) , 378-379
Abstract
Research from JAMA Neurology — Procainamide-Induced Myasthenia-like Weakness in a Patient With Peripheral NeuropathyKeywords
This publication has 8 references indexed in Scilit:
- Disorders of Neuromuscular Transmission Caused by DrugsNew England Journal of Medicine, 1979
- Double‐Step nerve stimulation test for myasthenic block: Sensitization of postactivation exhaustion by ischemiaAnnals of Neurology, 1977
- ELECTRICAL TESTING IN MYASTHENIA GRAVIS*Annals of the New York Academy of Sciences, 1971
- Procainamide--a Hazard in Myasthenia GravisArchives of Neurology, 1965
- EFFECTS OF CENTRAL DEPRESSANT DRUGS UPON ACETYLCHOLINE RELEASEBritish Journal of Pharmacology and Chemotherapy, 1964
- THE GANGLION BLOCKING ACTION OF PROCAINAMIDEBritish Journal of Pharmacology and Chemotherapy, 1964
- THE TREATMENT OF MYOTONIA: A CONTROLLED CLINICAL TRIALBrain, 1959
- ELECTROMYOGRAPHIC STUDY OF DEFECTS OF NEUROMUSCULAR TRANSMISSION IN HUMAN POLIOMYELITISArchives of Neurology And Psychiatry, 1948